2016 Update of the Portuguese Recommendations for the Use of Biological Therapies in Children and Adolescents with Juvenile Idiopathic Arthritis

To provide evidence-based guidance for the rational and safe prescription of biological therapies in children and adolescents with juvenile idiopathic arthritis (JIAs) considering the latest available evidence and the new licensed biologics. Rheumatologists and Pediatricians with expertise in Pediat...

Full description

Bibliographic Details
Main Author: Santos, MJ (author)
Other Authors: Conde, M (author), Mourão, AF (author), Ramos, FO (author), Cabral, M (author), Brito, I (author), Ramos, MP (author), Marques, RC (author), Gomes, SM (author), Guedes, M (author), Gonçalves, MJ (author), Estanqueiro, P (author), Zilhão, C (author), Rodrigues, M (author), Henriques, C (author), Salgado, M (author), Canhão, H (author), Fonseca, JE (author), Gomes, JM (author)
Format: article
Language:eng
Published: 2017
Subjects:
Juvenile Idiopathic Arthritis
Biological Agents
Child
Adolescent
HDE REUM PED
Online Access:http://hdl.handle.net/10400.17/2657
Country:Portugal
Oai:oai:repositorio.chlc.min-saude.pt:10400.17/2657

Internet

http://hdl.handle.net/10400.17/2657

Similar Items